VOLIN and KJON-Two novel hyperdiploid myeloma cell lines

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Multiple myeloma is categorized into hyperdiploid (HRD) and nonhyperdiploid (NHRD) genetic subgroups.
• Existing human myeloma cell lines predominantly originate from NHRD patients, creating a gap in research for HRD myeloma, which affects approximately half of all patients.
• Representative preclinical studies require cell lines derived from HRD myeloma patients.

Purpose of the Study:

• To introduce and characterize two novel multiple myeloma cell lines, VOLIN and KJON, derived from HRD patients.
• To provide essential tools for advancing the understanding of HRD multiple myeloma biology and for preclinical drug screening.

Main Methods:

• Development of two new cell lines (VOLIN and KJON) from HRD multiple myeloma patients.
• Comprehensive characterization including chromosomal content, genetic aberrations, gene expression, immunophenotype, and growth characteristics.
• Genotyping to confirm shared genetic profiles between cell lines and their primary tumors.

Main Results:

• VOLIN and KJON cell lines were successfully established from HRD multiple myeloma patients.
• Both cell lines maintained the genotype of their corresponding primary tumors.
• Detailed characterization revealed specific genetic and immunophenotypic profiles, with neither cell line harboring immunoglobulin heavy chain translocations.

Conclusions:

• The novel VOLIN and KJON cell lines represent valuable tools for multiple myeloma research, particularly for studying the HRD subtype.
• These cell lines will facilitate more representative preclinical studies and enhance the understanding of HRD myeloma biology.
• The availability of these HRD cell lines addresses a critical need in the field of multiple myeloma research.